Harmony Biosciences Holdings (HRMY) Tax Rate (2021 - 2026)
Harmony Biosciences Holdings (HRMY) reported Tax Rate of 18.14% for Q1 2026, down 218.0% on a YoY basis from 15.37% in Q1 2025, and up 130.18% sequentially from 60.11% in Q4 2025.
Harmony Biosciences Holdings (HRMY) Tax Rate (2021 - 2026) Analysis & Trends
Harmony Biosciences Holdings (HRMY) has 6 years of Tax Rate data on file, last reported at 18.14% in Q1 2026.
- For the quarter ending Q1 2026, Tax Rate fell 218.0% year-over-year to 18.14%; the trailing twelve-month figure through Mar 2026 stood at 4.65% (down 1791.0% YoY), and the FY2025 full-year result was 6.32%, down 1782.0% from the prior year.
- Tax Rate improved to 18.14% in Q1 2026, from 60.11% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 46.57% in Q2 2024 to a low of 1003.84% in Q3 2022.
- A 5-year average of 44.13% and a median of 20.32% in 2025 frame the typical range for Tax Rate.
- Across the five-year window, Tax Rate sank 101241 bps in 2022 and soared 102964 bps in 2023, its largest moves.
- Tracing HRMY's Tax Rate over 5 years: stood at 9.99% in 2022, then jumped by 430 bps to 32.96% in 2023, then tumbled by 64 bps to 11.9% in 2024, then tumbled by 605 bps to 60.11% in 2025, then jumped by 130 bps to 18.14% in 2026.
- Business Quant data shows HRMY's Tax Rate at 18.14% in Q1 2026, 60.11% in Q4 2025, and 24.63% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.34% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.29% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -5.41% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 17.68% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 12.51% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 33.09% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Harmony Biosciences Holdings | 2.07 Bn | 1.55 Bn | 170.88 Mn | 18.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.14% |
| Mar 31, 2026 | 18.14% |
| Mar 31, 2026 | 18.14% |
| Dec 31, 2025 | -60.11% |
| Dec 31, 2025 | -60.11% |
| Dec 31, 2025 | -60.11% |
| Sep 30, 2025 | 24.63% |
| Sep 30, 2025 | 24.63% |
| Sep 30, 2025 | 24.63% |
| Jun 30, 2025 | 19.87% |
| Jun 30, 2025 | 19.87% |
| Jun 30, 2025 | 19.87% |
| Mar 31, 2025 | 20.32% |
| Mar 31, 2025 | 20.32% |
| Mar 31, 2025 | 20.32% |
| Dec 31, 2024 | 11.90% |
| Dec 31, 2024 | 11.90% |
| Dec 31, 2024 | 11.90% |
| Sep 30, 2024 | 25.86% |
| Sep 30, 2024 | 25.86% |